drugset / Trial / NCT05365477

Empiric Versus Selective Prevention Strategies for Kidney Stone Disease

NCT05365477 ↗

Phase 4 Completed 56 enrolled Vanderbilt University Medical Center
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The aims of this study are to 1) Conduct a randomized clinical trial of selective versus empiric diet plus pharmacologic therapy in high-risk stone formers and 2) Determine adverse effects from, and adherence to selective and empiric strategies.

Timeline

Start
2022-08-04
Primary completion
2025-09-26
Completion
2026-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Allopurinol Small molecule 300 mg —
Comparator Indapamide Small molecule 1.25 mg —
Comparator Indapamide Small molecule 2.5 mg —
Comparator POTASSIUM CITRATE ANHYDROUS Small molecule 15 meq —
Comparator POTASSIUM CITRATE ANHYDROUS Small molecule 30 meq —
Subject Potassium Chloride Small molecule 20 meq —

Indications